Detalles de la búsqueda
1.
Demystifying BRAF Mutation Status in Colorectal Liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions.
Ann Surg
; 278(3): e540-e548, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36453261
2.
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 23(7): 876-887, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35636444
3.
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
Br J Cancer
; 127(5): 957-967, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35665778
4.
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer.
Oncologist
; 25(8): 661-668, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32202020
5.
Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer.
Future Oncol
; 16(32): 2645-2660, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32776795
6.
CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer.
Br J Cancer
; 121(7): 593-599, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31474758
7.
Prognostic evaluation in palliative care: final results from a prospective cohort study.
Support Care Cancer
; 27(6): 2095-2102, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30229339
8.
The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.
BMC Cancer
; 18(1): 98, 2018 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29370781
9.
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial.
Br J Cancer
; 117(8): 1099-1104, 2017 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28926529
10.
HLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer.
Int J Mol Sci
; 18(7)2017 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28653974
11.
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines.
Int J Cancer
; 137(12): 2971-80, 2015 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26099996
12.
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer.
Future Oncol
; 11(4): 629-40, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25686118
13.
Risk of unplanned visits for colorectal cancer outpatients receiving chemotherapy: a case-crossover study.
Support Care Cancer
; 22(9): 2527-33, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24728616
14.
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.
Cancers (Basel)
; 15(22)2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001711
15.
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation.
J Clin Oncol
; 41(34): 5263-5273, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37535876
16.
The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer.
Cancers (Basel)
; 15(1)2022 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36612170
17.
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy.
J Chemother
; 34(8): 543-549, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35156913
18.
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index.
J Gastrointest Cancer
; 53(2): 289-298, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33544375
19.
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial.
J Clin Oncol
; 40(14): 1562-1573, 2022 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35258987
20.
Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer.
Cancers (Basel)
; 13(14)2021 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34298718